RIVIVE

Serial Number 97323739
Registration 7347866
700

Registration Progress

Application Filed
Mar 22, 2022
Under Examination
Apr 11, 2023
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Apr 2, 2024

Trademark Image

RIVIVE

Basic Information

Serial Number
97323739
Registration Number
7347866
Filing Date
March 22, 2022
Registration Date
April 2, 2024
Published for Opposition
February 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 2, 2024
Registration
Registered
Classes
005

Rights Holder

Harm Reduction Therapeutics, Inc.

03
Address
4800 Montgomery Lane, Suite 400
Bethesda, MD 20814

Ownership History

Harm Reduction Therapeutics, Inc.

Original Applicant
03
Bethesda, MD

Harm Reduction Therapeutics, Inc.

Owner at Publication
03
Bethesda, MD

Harm Reduction Therapeutics, Inc.

Original Registrant
03
Bethesda, MD

Legal Representation

Attorney
Joseph W. Berenato, III

USPTO Deadlines

Next Deadline
1521 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240402)
Due Date
April 02, 2030
Grace Period Ends
October 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Apr 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 23, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 22, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 22, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 30, 2024 IUAF S USE AMENDMENT FILED Loading...
Feb 21, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 30, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 27, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 11, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 6, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Intra-nasal sprays containing naloxone for medical purposes
First Use Anywhere: Dec 18, 2023
First Use in Commerce: Jan 29, 2024

Additional Information

Translation
The English translation of the word "RIVIVE" in the mark is "RELIVES".

Classification

International Classes
005